Evènement Investisseurs Vaccins
Sanofi a eu le plaisir de convier investisseurs et analystes à participer à son Vaccines Investor Event en personne le 29 juin 2023
Avec
Paul Hudson
Chief Executive Officer
Thomas Triomphe
Head of Vaccines Business Unit
Jean-Francois Toussaint
Head of Vaccines R&D
Kimberly Tutwiler
Head of RSV Franchise
Bill Averbeck
Head of Influenza Franchise
Saranya Sridhar
Head of Translational Medicine
Thomas Grenier
Head of Vaccines Franchise & Product Strategy
Frank DeRosa
Head of Research for mRNA Center of Excellence
Sally Mossman
Head Vaccines Research Portfolio Strategy
Dr William Geisler, MD, MPH
Professor of Medicine & Epidemiology, University of Alabama at Birmingham